Semushonga unogona kutadzisa COVID_19,cepharanthinendiwo mushonga unoshanda wakatorwa kubva kuStephania, mushonga wechiChinese wechinyakare.Mushonga weChinese patent wakanyorwa muChina nekune dzimwe nyika kwemakore anopfuura makumi mana.
Musi waChivabvu 10, 2022, masayendisiti echiChinese akawana mushonga wecovid_ 19 mishonga mitsva yakawana patents dzepatent yenyika.
Ruzivo urwu parwakangobuda, zvainakidza zvikuru Covid 19 isati yagadziriswa.Kunyangwe cepharanthine ichiri mudanho rekutsvagisa zvinodhaka nekuvandudza uye isati yashandiswa zviri pamutemo mukudzidzira kwekiriniki, zvakare inhau dzakanaka kwazvo kune. mamiriro azvino eCovid 19. Zvakare, maererano nemishumo yenhau, dzimwe nyanzvi dzeAmerica dzakambodhinda mapepa musainzi uye dzakasimbisa kuti tsvakiridzo yecepharanthine iri nani pane paxlovid, iyo yakabvumidzwa kunyorwa. Parizvino, wekuCanada. bhizinesi remishonga rakasangana neUS FDA kuti iite ongororo yekiriniki pakurapwa kweCCIDID-19 neCepharanthine.
Cepharanthine(CEP) ialkaloid inongoitika inotorwa kubva kuna Stephania cepharantha Hayata uye yakaratidza kuve neyakasarudzika anti-kuzvimba, antioxidative, immunomodulating, antiparasitic, uye antiviral properties.
Kugona kwayo kwekurapa senge antiviral agent haina kumbobvira yakakosha kupfuura mukurwisa COVID-19 yakakonzerwa neyakakomba acute kufema chirwere checonavirus type 2 (SARS-CoV-2) hutachiona.
Pakati pevashoma varidzi vepa patent, isu tine ma patent ane chekuita nazvoCepharanthine.
Yunnan Hande Bio-tech Co., Ltd. inogadzira uye mutengesi ane 28+ ruzivo rwekuwedzeredza kubviswa uye kupatsanurwa kwezvirimwa.Cepharanthinekubva kare munaAugust 2011.Patent yedu inotsanangura zvakadzama kuti stephanine inotorwa sei.Kana uchida Cepharanthine munyaya iyi, usanonoka, tapota taura nesu pakarepo.
Nguva yekutumira: May-16-2022